Liu Zhuowei

Research areas: Surgical treatment of urinary tract tumors, minimally invasive treatment with robot-assisted/laparoscopic surgery, comprehensive treatment of bladder cancer and testicular cancer, and pediatric oncological surgery.

Cutting-edge technologies: Pioneered domestically in modified robot-assisted/laparoscopic retroperitoneal lymph node dissection for testicular cancer and ultra-extended lymph node dissection for bladder cancer. Director of the Expert Committee of the first international training center for the da Vinci Surgical Robot in South China. Since 2011, has published over 20 papers as corresponding author/first author in journals such as Cancer Cell (winner of the 2022 Cell Press China Paper Award), Nature Communications, and the International Journal of Surgery.

Specializes in treating: bladder cancer, testicular cancer, kidney cancer, prostate cancer, and pediatric solid tumors.

Academic Highlights and Core Values: Deputy Director of Sun Yat-sen University Cancer Center and Vice President of the hospital; Director of the National Residency Training Base for Surgery at Sun Yat-sen University Cancer Center; Vice Chairman of the Multidisciplinary Committee on Tumor Treatment of the Chinese Anti-Cancer Association; and Chairman-elect of the Robotic Surgery Branch of the Guangdong Medical Association. Recipient of the National Advanced Worker in the Health System and the Outstanding Young Scientist Award in Urological Oncology in China. Holds a leading position nationwide in the field of robotic minimally invasive surgery for urological tumors.